Clinical Trials Logo

Clinical Trial Summary

Rebion (Rebiscan, Inc) has developed a noninvasive, handheld device that uses retinal birefringence scanning (RBS) to rapidly assess eye fixation and retinal integrity in adults and children. The proprietary technology uses a scanned annulus of polarized laser light to create a signature that confirms central fixation within seconds. The project described herein aims to provide accurate assessment of brain dysfunction in TBI (Traumatic Brain Injury) patients through the use of the developed device, which is called the Head and Intraocular Trauma Test (HITT) device.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Wave Form Signals Coming From the Eye in a Healthy Cohort

NCT number NCT03653936
Study type Observational
Source Rebiscan, Inc.
Contact
Status Completed
Phase
Start date April 1, 2018
Completion date November 30, 2018